Longevity News

CXCR6+ natural killer cell immunotherapy preserves CD4+ T helper cells in humanized mice

Source: Frontiers - Health • Published: 10 Aug 2026, 00:00

CXCR6+ natural killer cell immunotherapy preserves CD4+ T helper cells in humanized mice

Examines whether CXCR6-positive natural killer cells provide enhanced antiviral activity and preserve CD4+ T cells after HIV exposure in humanized mice.

Key Takeaways
  • Because HIV-responsive adaptive NK-cell activity is enriched among CXC chemokine receptor 6-positive (CXCR6 + )
  • In co-cultures with HIV-infected primary CD4 + T cells
  • HIV-Env vaccination further enriched NK cells with enhanced therapeutic activity
Read Original Source

Continue exploring

Related longevity signals

Frontiers - HealthSpatial immune ecosystems and therapy resistance in large B-cell lymphoma: from single-cell multi-omics to immunotherapy-matched validationReview of how single-cell and spatial multi-omics map tumor and immune architectures in large B-cell lymphoma and guide pathology-ready biomarker development.Nature - BiotechnologyEnhancing iNKT cell immunotherapy through the integration of optimized CAR endodomains and iNKT engagersReports optimization of CAR-iNKT designs and complementary iNKT-specific engagers to boost cell therapy efficacy against multiple myeloma.Nature - BiotechnologyDroplet digital PCR reveals that transgene copy number determines lifespan in SOD1G93A ALS miceA methods-focused research article examining how a precise DNA quantification technique maps transgene copy variation to disease trajectory in an ALS mouse model.Fight Aging!Senescent Cells in Metabolic DisordersReview of how senescent cells and their inflammatory secretions interact with metabolic dysfunction and drive diseases like fatty liver and diabetes.